A.G. Zuiable
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
-
- Cancer Treatment and Pharmacology
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 6
- Multiple Myeloma Research and Treatments 5
- Hematopoietic Stem Cell Transplantation 5
- Platelet Disorders and Treatments 4
-
- Autoimmune Bullous Skin Diseases 2
- Co-authors
- Martin Eric Gore (4 shared papers)U. M. Hegde (3 shared papers)Simon T. Ball (3 shared papers)B. C. Millar (2 shared papers)A. Lakhani (6 shared papers)Ann C. Nandi (6 shared papers)T J McElwain (2 shared papers)R. L. Powles (4 shared papers)
- Journals
- The Lancet (5 papers)British Journal of Haematology (5 papers)Cancer Chemotherapy and Pharmacology (1 paper)British Journal of Dermatology (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
A.G. Zuiable
20 papers receiving 405 citations
Peers
Comparison fields: 5 of 51
- Hematology 352
- Oncology 138
- Genetics 56
- Immunology 55
- Molecular Biology 110
Countries citing papers authored by A.G. Zuiable
This map shows the geographic impact of A.G. Zuiable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. Zuiable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. Zuiable more than expected).
Fields of papers citing papers by A.G. Zuiable
This network shows the impact of papers produced by A.G. Zuiable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. Zuiable. The network helps show where A.G. Zuiable may publish in the future.
Co-authors
The 25 scholars most cited alongside A.G. Zuiable, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 173 | |
| 2 | Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. | 1988 | 61 |
| 3 | 1985 | 34 | |
| 4 | 1989 | 32 | |
| 5 | 1986 | 20 | |
| 6 | 1989 | 16 | |
| 7 | 1985 | 14 | |
| 8 | 1989 | 14 | |
| 9 | 1986 | 13 | |
| 10 | 1985 | 12 | |
| 11 | 1985 | 8 | |
| 12 | 2008 | 8 | |
| 13 | 1990 | 7 | |
| 14 | 1985 | 7 | |
| 15 | The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia. | 1989 | 7 |
| 16 | 1988 | 6 | |
| 17 | 1986 | 4 | |
| 18 | 1989 | 3 | |
| 19 | 2008 | 2 | |
| 20 | 1987 | 1 |
About A.G. Zuiable
A.G. Zuiable is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 442 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Platelet Disorders and Treatments (4 papers), Acute Lymphoblastic Leukemia research (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (352 citations), Oncology (138 citations), Genetics (56 citations), Immunology (55 citations) and Molecular Biology (110 citations). A.G. Zuiable has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Martin Eric Gore, U. M. Hegde, Simon T. Ball, B. C. Millar, A. Lakhani, Ann C. Nandi, T J McElwain, R. L. Powles, M Meldrum and Peter I. CLARK. Their work appears in journals such as The Lancet, British Journal of Haematology, Cancer Chemotherapy and Pharmacology, British Journal of Dermatology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.